University of Groningen Anticancer Effects of 15d-Prostaglandin-J(2) in Wild-Type and Doxorubicin-Resistant Ovarian Cancer Cells
暂无分享,去创建一个
[1] M. McNutt,et al. SIRT1 is regulated by a PPARγ–SIRT1 negative feedback loop associated with senescence , 2010, Nucleic acids research.
[2] M. Horinaka,et al. Histone Deacetylase Inhibitors and 15-Deoxy-Δ12,14-Prostaglandin J2 Synergistically Induce Apoptosis , 2010, Clinical Cancer Research.
[3] J. Kwak,et al. 15d-PGJ2 Induces Apoptosis by Reactive Oxygen Species–mediated Inactivation of Akt in Leukemia and Colorectal Cancer Cells and Shows In vivo Antitumor Activity , 2009, Clinical Cancer Research.
[4] H. Verheul,et al. Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib. , 2009, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[5] G. Marshall,et al. The critical role of the class III histone deacetylase SIRT1 in cancer. , 2009, Cancer research.
[6] H. Höfler,et al. The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients , 2007, British Journal of Cancer.
[7] Y. Surh,et al. 15 -Deoxy -Δ12,14 -prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors , 2006 .
[8] O. Sezer,et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma , 2006, Anti-cancer drugs.
[9] A. Rebbaa,et al. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1. , 2005, Cancer research.
[10] Alan Richardson,et al. Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[11] J. Nesland,et al. Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma , 2005, Cancer.
[12] M. Mayo,et al. Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase , 2004, The EMBO journal.
[13] H. Nakshatri,et al. NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4* , 2003, Journal of Biological Chemistry.
[14] E. Hammond,et al. Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins. , 2002, Molecular cancer therapeutics.
[15] C. Glass,et al. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] Marty W. Mayo,et al. NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis , 1999, Molecular and Cellular Biology.
[17] J. Lehmann,et al. The structure - Activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones , 1996 .
[18] W. Smith. Prostanoid biosynthesis and mechanisms of action. , 1992, The American journal of physiology.
[19] Ruchi Bansal,et al. Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo. , 2009, Neoplasia.
[20] S. K. Kang,et al. 15-deoxy-(Delta12,14)-prostaglandin J2 (15d-PGJ2) induces cell death through caspase-independent mechanism in A172 human glioma cells. , 2006, Neurochemical research.
[21] K. Itoh,et al. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). , 2004, Molecular and cellular biology.
[22] W. Koenig,et al. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. , 1998, Nature.